News and Updates

In February, Vertex announced they were beginning a clinical trial for VX-880, their stem cell-derived therapy for use in people…

Vertex is currently enrolling for a clinical trial evaluating their stem cell derived islet cell infusion therapy, VX-880.

Breakthrough T1D and NIH bring together top scientists and engineers to strategize on how to allow implanted beta cells to…

Here is Dr. Camillo Ricordi to share his key takeaways from day 4 from the American Diabetes Association's Scientific Sessions.

You thought that beta cells were passive participants in their own immune-mediated death, leading to type 1 diabetes (T1D)? Wrong.

The Breakthrough T1D New England Center of Excellence will focus on protecting the stem cell-derived beta cells from rejection by…

Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D).

Douglas Melton, Ph.D., can now produce unlimited quantities of beta cells. He now wants to evade the immune attack. See…

Dr. Robert Langer co-founded Moderna, who gained emergency use approval for its COVID vaccine. Watch the video to find out…

Hear Dr. Elad Sintov talk about his research into beta cell replacement technology with our new video.